[go: up one dir, main page]

AU2003279461A8 - Disorders of lipid metabolism - Google Patents

Disorders of lipid metabolism

Info

Publication number
AU2003279461A8
AU2003279461A8 AU2003279461A AU2003279461A AU2003279461A8 AU 2003279461 A8 AU2003279461 A8 AU 2003279461A8 AU 2003279461 A AU2003279461 A AU 2003279461A AU 2003279461 A AU2003279461 A AU 2003279461A AU 2003279461 A8 AU2003279461 A8 AU 2003279461A8
Authority
AU
Australia
Prior art keywords
disorders
lipid metabolism
metabolism
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003279461A
Other versions
AU2003279461A1 (en
Inventor
Carol Christine Shoulders
James Scott
Paul Simon Freemont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0226039A external-priority patent/GB0226039D0/en
Priority claimed from GB0226152A external-priority patent/GB0226152D0/en
Priority claimed from GB0305463A external-priority patent/GB0305463D0/en
Priority claimed from GB0323689A external-priority patent/GB0323689D0/en
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Publication of AU2003279461A8 publication Critical patent/AU2003279461A8/en
Publication of AU2003279461A1 publication Critical patent/AU2003279461A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/044Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003279461A 2002-11-07 2003-11-07 Disorders of lipid metabolism Abandoned AU2003279461A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0226039A GB0226039D0 (en) 2002-11-07 2002-11-07 Conditions of lipid excess
GB0226039.6 2002-11-07
GB0226152.7 2002-11-08
GB0226152A GB0226152D0 (en) 2002-11-08 2002-11-08 Conditions of lipid excess
GB0305463A GB0305463D0 (en) 2003-03-10 2003-03-10 Disorders of lipid metabolism
GB0305463.2 2003-03-10
GB0323689A GB0323689D0 (en) 2003-10-09 2003-10-09 Disorders of lipid metabolism
GB0323689.0 2003-10-09
PCT/GB2003/004816 WO2004042064A2 (en) 2002-11-07 2003-11-07 Disorders of lipid metabolism

Publications (2)

Publication Number Publication Date
AU2003279461A8 true AU2003279461A8 (en) 2004-06-07
AU2003279461A1 AU2003279461A1 (en) 2004-06-07

Family

ID=32314923

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003279461A Abandoned AU2003279461A1 (en) 2002-11-07 2003-11-07 Disorders of lipid metabolism

Country Status (2)

Country Link
AU (1) AU2003279461A1 (en)
WO (1) WO2004042064A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018014366A (en) * 2016-05-27 2019-04-11 Synthex Inc Protein interfaces.

Also Published As

Publication number Publication date
WO2004042064A3 (en) 2004-12-02
AU2003279461A1 (en) 2004-06-07
WO2004042064A2 (en) 2004-05-21

Similar Documents

Publication Publication Date Title
IL165820A0 (en) Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
AU2003205950A8 (en) Placement of alternative advertisements
IL163863A0 (en) Form of presentation for3-Ä(2-äÄ4-(hexyloxycarbonylamino-imino-methyl)-phenylaminoÜmethylü-1-methyl-1H-benzimidaz
AU2003298738A8 (en) Liposomal formulations
AU2003286728A8 (en) Compounds for the treatment of metabolic disorders
AU2003228648A8 (en) Securitization of sales participation certificates
AU2003232956A8 (en) Purchase of services
AU2003302320A8 (en) Seterocyclic quinones as pharmaceutical agents
AU2003279461A8 (en) Disorders of lipid metabolism
GB0323689D0 (en) Disorders of lipid metabolism
GB0305463D0 (en) Disorders of lipid metabolism
AU2003266714A8 (en) Phospholipid derivative
AU2003266210A8 (en) Use of mas-compounds for treating diseases associated with lipid metabolism
IL172377A0 (en) 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders
GB0226152D0 (en) Conditions of lipid excess
GB0226039D0 (en) Conditions of lipid excess
HK1075251A (en) Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
AU2002361078A1 (en) Markers for sugar/lipid metabolic disorders and utilization thereof
GB0218936D0 (en) Lipid metabolism enhancing drink
TW534417U (en) Structure improvement of advertisement framework
EP1383380A4 (en) Fizz1 for metabolism regulation
GB0209859D0 (en) Lipid compositions
GB2380661B (en) Confectionery support
HU0200197V0 (en) Advertising for stairs
TW578557U (en) Structure of wearable dribbler stand

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase